Trademark: 97386629
Word
MPOVO
Status
Pending
Status Code
730
Status Date
Friday, February 16, 2024
Serial Number
97386629
Mark Type
4000
Filing Date
Thursday, April 28, 2022
Published for Opposition
Tuesday, March 28, 2023

Trademark Owner History
TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and skin disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events
Feb 17, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 16, 2024
Sou Extension 1 Granted
Nov 24, 2023
Sou Extension 1 Filed
Feb 14, 2024
Case Assigned To Intent To Use Paralegal
Jan 4, 2024
Notice Of Revival - E-Mailed
Jan 4, 2024
Sou Extension Received With Teas Petition
Jan 4, 2024
Notice Of Revival - E-Mailed
Jan 4, 2024
Petition To Revive-Granted
Jan 4, 2024
Teas Petition To Revive Received
Dec 26, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 25, 2023
Abandonment - No Use Statement Filed
May 23, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 28, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 28, 2023
Published For Opposition
Mar 8, 2023
Notification Of Notice Of Publication E-Mailed
Feb 21, 2023
Approved For Pub - Principal Register
Feb 21, 2023
Examiner's Amendment Entered
Feb 21, 2023
Notification Of Examiners Amendment E-Mailed
Feb 21, 2023
Examiners Amendment E-Mailed
Feb 21, 2023
Examiners Amendment -Written
Feb 15, 2023
Notification Of Non-Final Action E-Mailed
Feb 15, 2023
Non-Final Action E-Mailed
Feb 15, 2023
Non-Final Action Written
Feb 7, 2023
Assigned To Examiner
Feb 2, 2023
Teas Change Of Correspondence Received
Feb 2, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 2, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 2, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 7, 2022
Teas Change Of Correspondence Received
Jul 7, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 7, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 3, 2022
New Application Office Supplied Data Entered
May 2, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24